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Preamble
This document is an American College of Cardiology
Foundation (ACCF) health policy statement and is in-
tended to promote or advocate a position, be informationalin nature, and may offer guidance to the stakeholder
community regarding the American College of Cardiology’s
stance on healthcare policies and programs. Health policy
statements are not intended to offer clinical guidance and do
not contradict existing ACCF clinical policy. They are
overseen by the ACCF Clinical Quality Committee
(CQC), the group responsible for developing and imple-
menting all health policy statement policies and procedures
related to topic selection, commissioning writing commit-
tees, and defining document development methodologies.
The CQC brings together various areas of the College such
as the Advocacy Committee, the National Cardiovascular
Data Registry, the ACCF/American Heart Association
Task Forces on Guidelines and Performance Measures, and
the Appropriate Use Criteria Steering Committee. The
CQC recommended the development of this Health Policy
Statement to document the College’s official position on
patient-centered care (PCC).
To avoid actual, potential, or perceived conflicts of
interest that may arise as a result of industry relationships or
personal interests among the writing committee, all mem-
bers of the writing committee, as well as peer reviewers of
the document, are asked to disclose all current healthcare-
related relationships, including those in existence 12 months
before initiating the writing effort. The ACCF CQC
reviews these disclosures to determine what companies
make products (on market or in development) that pertain
to the document under development. Using this informa-
tion, the CQC forms a writing committee that includes a
majority of members with no relevant relationships with
industry or other entities (RWI), led by a chair with no
relevant RWI. Authors with relevant RWI are not permit-
ted to draft or vote on text or recommendations pertaining
to their RWI. RWI is reviewed on all conference calls and
updated as changes occur. Author and peer reviewer RWI
pertinent to this document are disclosed in Appendices 1
and 2, respectively. Additionally, to ensure complete
transparency, authors’ comprehensive disclosure informa-
tion—including RWI not pertinent to this document—is
available online (see Online Appendix). Disclosure infor-
mation for the ACCF CQC is also available online at
www.cardiosource.org/ACC/About-ACC/Leadership/
Guidelines-and-Documents-Task-Forces.aspx, as well as
the ACCF disclosure policy for document development
at www.cardiosource.org/Science-And-Quality/Practice-
Guidelines-and-Quality-Standards/Relationships-With-
Industry-Policy.aspx.
The work of the writing committee was supported
exclusively by the ACCF without commercial support.
Writing committee members volunteered their time to this
effort. Conference calls of the writing committee were
confidential and attended only by committee members.
Joseph P. Drozda Jr., MD, FACC, Chair
ACCF Clinical Quality Committee
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1.1. Document Development Process
1.1.1. Writing Committee Organization
The writing committee consisted of a broad range of members
representing general medicine, the cardiac care team, consum-
ers, and advocacy. Cardiac care team members included those
with expertise in general cardiology and in specialty areas such
as pediatric cardiology, geriatric cardiology, and healthcare
disparities, as well as physicians and nurses in both private
practice and academia, including those who work in rural,
suburban, and urban areas. A pharmacist was also included on
the writing committee, along with a healthcare services re-
searcher and 2 consumers of cardiovascular care. Expertise in
patient adherence and patient education was reflected on the
committee as well. This writing committee met the ACCF’s
disclosure requirements as described in the Preamble.
1.1.2. Document Development and Approval
The writing committee convened by conference call and e-mail
to finalize the document outline, develop the initial draft, revise
the draft per committee feedback, and ultimately sign off on
the document for external peer review. Peer review consisted of
16 reviewers representing 281 comments. Comments were
reviewed and addressed by the writing committee. A CQC
member served as lead reviewer to ensure that all comments
were addressed adequately. Both the writing committee and
CQC approved the final document to be sent for board review.
The ACCF Board of Trustees reviewed the document, includ-
ing all peer review comments and writing committee re-
sponses, and approved the document in March 2012. The
document is considered current until the CQC revises or with-
draws it from publication.
2. Purpose and Background
This statement presents a review of the current state of
patient-centered care (PCC) in cardiovascular medicine,
details the many multidisciplinary efforts that are ongoing in
its development, and underscores areas of needed research.
The document is an outgrowth of the commitment by the
ACCF beginning in 2009 to develop a patient-centered
approach to cardiovascular care.
In 2001, the Institute of Medicine issued the report,
Crossing the Quality Chasm on the status of health care in the
nited States (1). In this report, 6 characteristics of an
ffective healthcare system were identified: The system should
e safe, effective, patient-centered, timely, efficient, and equi-
able. PCC was defined as care that is “respectful of and
esponsive to individual patient preferences, needs, and
alues and ensures that patient values guide all clinical
ecisions” (1, p. 3). The term PCC has been used to
escribe an approach to care that empowers patients to
ecome active participants in their own health care (2).PCC can be thought of as an amalgamation of patient
education, self-care, and evidence-based models of practice
(3,4). Hobbs suggested that “PCC is a poorly conceptual-
ized phenomenon and can indicate anything from soothing
room design, emotional support of patients, customization
of meals, to support of patient decision making” (5, p. 52).
Berwick defined PCC as “the experience (to the extent the
informed, individual patient desires it) of transparency,
individualization, recognition, respect, dignity, and choice
in all matters, without exception, related to one’s person,
circumstances, and relationships in health care” (6, p. w560).
At its foundation, PCC requires patient knowledge and
self-monitoring. Shared decision-making (SDM) is a tenet
of PCC, but there can be no involvement in SDM by the
patient without the provision of information, including the
existence of alternatives and their merits and shortcomings
(1). Health literacy is a prominent component of PCC, as it
is the foundation for self-management programs and the
ability of patients to engage in productive interactions with
their clinicians about the optimal course of care (7,8).
Although there is much theoretical support for patient-
centered approaches to care (9–11), and although the
patient-centered model is widely advocated and believed to
be used in practice, actual evidence of effective use of PCC
in practice is somewhat limited (12–15). Intrinsic to the
PCC approach for patients with chronic disease are the
concepts of continued physician-to-patient communication
(16) and patients’ involvement in their care (2). To allow
patients with chronic cardiovascular disease (CVD) to
participate in their own care, they must first understand
their disease and be able to monitor the measures that
identify the status of their condition. However, patients’
needs for information to follow a patient-centered ap-
proach often remain unfulfilled (14,17,18). To provide
PCC, clinicians require focused education on PCC (19)
and properly aligned financial incentives for managing
patients with chronic diseases (20).
Much of the research in PCC has focused on assessments
of communication styles by clinicians or patients and
interventions to enhance patient–clinician communication
(21–23). In a study of 274 consecutive patients, receiving
more information from the physician and taking part in
decisions was the most desired patient choice (24). In a
survey of 2,500 adults visiting outpatient clinics, 76.2%
desired to be told of all possible adverse effects. Robinson et
al. (19) suggested that patient involvement in their own care
and individualized patient care were 2 measures that iden-
tified the essence of PCC and recommended developing
numeric scales to quantify these measures to assess the
quality of PCC. Spertus (25) has suggested that health
status measures (patients’ symptoms, function, and quality
of life) be incorporated into routine clinical practice so as to
better quantify the success of treatment as a measure of
PCC.
Low health literacy in patients limits a true PCC ap-
proach and contributes to a lack of medication adherence
2128 Walsh et al. JACC Vol. 59, No. 23, 2012
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people with chronic disease do not receive either proven
medical and behavioral interventions or adequate informa-
tion and support for self-management (27). Tarn et al. (28)
found that physicians often fail to communicate critical
elements of medication use, and similarly, Lin et al. (29)
found that many physicians do not achieve blood pressure
control in patients with hypertension because of incomplete
sharing of relevant treatment information. Hedblad et al.
(30), who studied causes for failure to reach target goals in
the management of hypertension, found that frequent blood
pressure measuring and patient communication with physi-
cians, a PCC approach, correlated with attaining blood
pressure goals. Pedersen et al. (31) have discussed the need
to consider a PCC approach to patients with implanted
devices (32). They suggested that PCC involving behavior
measures be included in device databases.
To advance care for chronic conditions, patient partici-
pation must be increased through self-management, educa-
tion, collaborative goal-setting, and treatment planning
(11). Moreover, clinicians have a responsibility to enhance
PCC through enhanced training in communication and
goal solicitation, serial assessments of patients’ health status
as a foundation for monitoring their disease and response to
treatment, explaining the impact of therapies on the out-
comes that patients value most, and creating time for such
interactions to occur. A practical approach to PCC is
embodied in the patient-centered medical home (PCMH)
(33). This concept includes adopting health information
technology and decision support systems, modifying clinical prac-
tice patterns, and ensuring continuity of care (34).
A successful PCC approach is also a foundation for
improving patients’ experiences with care. The success of
the healthcare system hinges on the ability to provide
patients with the respect, attention, and successful treat-
ment that satisfies their needs. In a series of articles defining
value in health care (35,36), Porter challenges the healthcare
system to emphasize patients’ outcomes, their survival, and
health status as the benchmark against which the expendi-
ture of resources are judged. PCC serially measures and
monitors these outcomes, judiciously investing in shared
decision-making to support the investment of resources that
optimize the outcomes that patients value most.
Elements of Patient-Centered Care
● Enhanced clinician–patient communication
● Health literacy
● Clinician-directed patient education
● Assessment of patient-centered outcomes
● Shared decision-making
● Collaborative care planning
● Collaborative goal setting
● Patient empowerment and self-management3. Elements of Patient-Centered Care
3.1. Enhanced Clinician–Patient Communication
3.1.1. Recommendation
Focused education and training around patient– clinician
communication should be incorporated into medical
school and continuing education curricula. Programs
should emphasize empathy, educational skills, and skills
in behavioral change strategies.
Clinician–patient communication is a central construct in
the overarching paradigm of PCC. The term patient-
centered communication has been used by experts in the field
of healthcare communication to include the patient perspec-
tive, and the psychosocial context along with shared under-
standing, power, and responsibility (37). In a consensus
statement developed by representatives from medical edu-
cation and professional organizations, 7 essential commu-
nication tasks were identified: 1) build the doctor–patient
relationship; 2) open the discussion; 3) gather information;
4) understand the patient’s perspective; 5) share informa-
tion; 6) reach agreement on problems and plans; and
7) provide closure (38). This is used in medical education
and provides a template for evaluating the various elements
of patient-centered communication. Patient-centered com-
munication, awareness of suboptimal health literacy, and the
importance of cultural competence in communication are
imperative for effective patient communication and have been
identified as key contributors to patient safety by the Joint
Commission (39).
For the cardiovascular clinician, clinician–patient com-
munication may occur in a broad spectrum of settings from
the bedside to the examination room, from the emergency
department to the cardiac catheterization or electrophysiol-
ogy laboratory, and in follow-up telephone communication.
The objectives in these disparate settings may include
eliciting a focused history, coaching a patient on preventive
lifestyle modifications strategies, instructing a patient on
oral anticoagulation therapy, obtaining informed consent
from a patient with an acute coronary syndrome about to
undergo emergency percutaneous coronary intervention,
and discussing end-of-life issues with a patient with heart
failure (HF). Each of these is likely to utilize different
proportions of empathy, educational skills, and, potentially,
skills in behavioral change strategies such as motivational
interviewing (40–44). Such encounters can be reinforced
with print materials, multidisciplinary referrals (e.g., a
dietitian), or a carefully scrutinized list of credible websites
to access for additional information.
In studying clinician–patient communication, Beckman
demonstrated that upon asking a patient to describe his or
her concerns, the clinician interrupted the patient after an
average of 18 s; most often, the physician redirected the
patient following the first-expressed concern, with subse-
quent discussion focused solely on that concern (45). If
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ruption or redirection, they are likely to express 3 concerns
per office visit (15). Clinicians may be skeptical about
allowing a patient to continue until he or she has listed all
concerns; however, patients who were allowed to complete
their concerns only spoke an average of 32 s (15). Conse-
quences of interrupting initial descriptions of concerns
include late-arising concerns and, worse, missed opportuni-
ties to gather important information (15). The value of the
patient-led information gathering was noted in a review by
Barrier et al. (46), who contended that the 2 most important
words to improve physician–patient communications are
“what else?” In addition to open-ended information gath-
ering, Mauksch et al. (47) further define attributes of
communication in the clinical encounter that blend quality-
enhancing characteristics with efficient time utilization.
Positive behavior attributes of the clinician include those of
being focused, reflective, curious, and tolerant of silence.
3.2. Health Literacy
3.2.1. Recommendation
Clinicians should be familiar with the sources of knowl-
edge appropriate for their patient populations, and have
access to a variety of educational materials to provide
their patients. Pamphlets, online programs, community
events, or group education sessions enable clinicians to
accommodate patients with different learning styles, cul-
tural realities, and socioeconomic status.
Health literacy is a prominent component of PCC, as it
is the foundation for self-management programs (8). The
American Medical Association’s 2001 video “Low Health
Literacy: You Can’t Tell By Looking” (48) has served as an
epiphany for many clinicians. This documentary demon-
strated that a person’s health literacy is not solely related to
the number of years completed in school, his or her
socioeconomic status, or native language. Even highly
educated, literate adults may be challenged by processing,
understanding, and using health-related information to
make appropriate decisions about their health. Low health
literacy can result in increased emergency department visits,
decreased adherence to medical recommendations, failure to
engage in healthy behaviors, inferior outcomes, and higher
healthcare costs (49).
Approximately 89 million people in the United States, or
one-third of the adult population, lack the level of health
literacy that would enable them to plan and follow through
on recommended diagnostic testing, medical treatments,
and maintenance of preventive health. Because it has been
demonstrated that those with low health literacy most often
hide their inability to read or understand information, it is
recommended that healthcare professionals practice univer-
sal precautions and approach all patients as though they read
at the sixth grade level (50). Older adults are at particular
risk for low health literacy levels, irrespective of their past
knowledge base and cognitive function. In a study of theassociation between age and health literacy among elderly
persons, when stratified by the number of years of educa-
tion, all educational strata showed similar deterioration in
mean Short Test of Functional Health Literacy in Adults
scores between age 65 and age 85 years (51). The U.S.
Department of Health and Human Services has published a
Web tool, A Quick Guide to Health Literacy and Older
Adults, recommending specific communication techniques
for this group (52).
Electronic media enable patients to access information
regarding their specific medical condition, according to their
specific interests and education level, facilitating more
meaningful and targeted discussions with clinicians (16).
his has positive downstream effects, with studies showing
igher measures of trust and satisfaction among patients and
edical practitioners when communication quality is en-
anced (53–56). Having access to various methods of
ontent delivery (e.g., pamphlet, online, library, organized
rograms, or group education sessions) facilitates accommo-
ation of different learning styles, cultural realities, and
ocioeconomic status of patient subgroups (16).
3.3. Clinician-Directed Patient Education
3.3.1. Recommendation
Patient education materials provided by clinicians should
be individually relevant and culturally appropriate, in-
corporate actionable goals, and acknowledge patients as
respected partners in their care.
A third vital component of PCC is educating and
motivating patients to become better stewards of their
health and more active participants in the management of
their diseases (8). Overcoming patient inertia, closing
knowledge gaps, acknowledging cultural and educational
diversities, and providing practical actionable resources to
help them attain positive outcomes are all goals and oppor-
tunities within this arena. The emergence of progressively
more complex and involved treatment options and external
pressures driving reductions in face-to-face time between
patients and clinicians are clear challenges to achieving these
goals and likely to become even more acute in both the short
and long term.
Communication between clinicians and patients typically
occurs according to the transactional model, where there is
a continuous exchange and deciphering of messages be-
tween the sender and receiver (16). This implies that both
parties bring knowledge, interest, and a willingness to
actively interact during the healthcare encounter. Within
the patient-centric model of care, the life experiences and
health attitudes of patients must also be incorporated into
communication and decision-making, such that consumers
become respected knowledge partners in their management
plans (16). If patients are not well informed, if clinicians are
oblivious to individual patient needs, or if actionable re-
sources are unavailable to leverage the knowledge gained,
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Similar to methods to enhance communication between
clinicians and patients, many options for clinician-delivered
patient education exist. In-person communication, online
resources, written materials, group seminars, and self-
monitoring tools all represent methods for informing and
activating patient consumers. Assessment of understanding
is an integral component of clinician-facilitated patient
education and must be incorporated into the process to
ensure success.
Unless patients clearly understand the information they
receive, they will not be able to apply it to improve their
care. Assessment of understanding can be accomplished
through the “teach back” method, which includes having the
patient explain in his or her own words what was just
learned or show that the patient is able to perform a
demonstrated task (57).
Rather than being unidirectional and prescriptive, con-
tent should be specifically tailored to the potential users.
Ideally, educational resources are developed and modified by
clinicians according to the expressed need or knowledge
gaps of patients in their practice. Such tools can be im-
proved by incorporating ongoing feedback from all stake-
holders (58).
Because the well-informed patient is more likely to be
actively engaged in his or her health management, clinician-
facilitated education is a vital component of PCC (16).
Education must be individually relevant, presented in a
culturally appropriate manner, incorporate actionable goals,
and acknowledge the patient as a respected partner in the
exchange of information. It is also important to recognize
that education is an ongoing process and can be built upon
over time (59). The learning must also be clearly under-
stood. These considerations are critical to healthcare deliv-
ery as improvements in care quality and outcomes cannot be
fully realized without the participation of activated and
well-informed patients who have reciprocal communica-
tions with clinicians.
3.4. Assessment of Patient-Centered Outcomes
3.4.1. Recommendation
Healthcare policies including performance measurement
systems and payment models should support and pro-
mote the explicit assessment of patient-centered out-
comes, including health status (symptoms, function, and
quality of life) as a foundation for guiding PCC. In
addition, policies should support the periodic assessment
of patients’ experiences with care as a means of assessing
the success of PCC.
Cardiovascular diseases manifest themselves to patients
through symptoms that can limit their ability to function
physically, socially, and mentally, as well as impair their
quality of life. Moreover, many of the available cardiovas-
cular treatments are capable of improving patients’ healthstatus. In fact, the strongest predictor of benefit from
percutaneous coronary revascularization is the severity of
patients’ angina at the time of treatment (60,61). A primary
goal of PCC is to assess the status of patients’ diseases and
its impact on their health, using this information as a
foundation for recommending a patient’s optimal therapy at
a given state of their disease.
Assessing patients’ health status entails explicitly inquir-
ing about patients’ symptoms, function, and quality of life,
and doing so frequently, given the variable course of CVD.
In fact, such assessments have been explicitly endorsed as
performance measures in coronary disease and HF (62,63).
Although traditional techniques have included physicians’
interpretation of patients’ health status with the Canadian
Cardiovascular Society classification system for angina (64)
and the New York Heart Association classification for HF
(65), these have been demonstrated to have poor inter-rater
reliability (66–69). More recently, disease-specific, patient-
reported outcome measures have been developed that enable
patients to report their health status in valid, reproducible,
and sensitive metrics (25). Although a complete description
of available measures is beyond the scope of this statement,
and new ones are continually being developed, recent
guidance by the Food and Drug Administration provides a
framework for evaluating the quality of such measures (70).
The use of such patient-reported outcomes can provide a
more sensitive assessment of patients’ conditions than those
that are physician-assessed (71).
Beyond health status, patient-centered outcomes can
include experiences with care (i.e., satisfaction and partici-
pation in shared decision-making). Explicitly quantifying
these domains can provide insight into the success of care in
meeting the needs of patients. Furthermore, systematically
capturing the experiences of patients within a practice can
provide insights into that practice’s ability in meeting
patients’ needs as well as provide a foundation for improving
the quality of PCC.
Emphasizing the need for a renewed focus on health
status, the Patient Centered Outcomes Research Institute
recently established its research priorities to center on
addressing the key questions of “Given my personal
characteristics, conditions, and preferences, what should
I expect will happen to me?” and “What are my options,
and what are the benefits and harms of these options?”
[72, p. e31(2)]. From the patients’ perspectives, their
prognosis and the impact of treatment are often centered
on their health status, including the way in which the
disease manifests itself. To deliver PCC, clinicians need
to understand patients’ current functioning and to be able
to explain the expected prognosis and treatment options
within a framework that patients understand. Doing so in
terms of their health status, can improve the quality of
communication and lay the foundation for shared
decision-making.
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3.5.1. Recommendation
Easy-to-use tools for both physicians and patients need
to be identified and developed to assist in implementing
shared decision-making strategies.
The clinician–patient relationship forms the cornerstone
of PCC. Despite patients’ strong desire for information and
despite long-standing professed advocacy by physicians for
patient involvement, patients vary in their desire to partic-
ipate in medical decision-making (73–77). Traditionally,
patients have had a non-participatory or passive role in
medical encounters, even when they have formulated im-
portant questions prior to their visit (73,77–79). This
passivity can result in patients being relatively uninformed
and unprepared to implement care plans (73).
Consequently, based on a positive relationship between
patient satisfaction with both communication and informa-
tion sharing by the physician, studies to encourage active
patient participation first emerged in the late 1970s. These
interventions occurred prior to physician encounters and
included coaching by a health educator or training booklets
to help patients identify and ask questions, negotiate med-
ical decisions, verify information (checking their under-
standing), provide information (provisional statements
about their concerns or symptoms), and reduce communi-
cation barriers (73,80–87). These interventions often, but
not always (88,89), improved the quantity of information
imparted, which resulted in enhanced patient participation
in decision making without increasing visit duration. This
led to improved diabetes and hypertension control, in-
creased patient self-reported health updates, and greater
patient and physician satisfaction (73,81,90–92). Kaplan et al.
found that “patients who ask questions, elicit treatment op-
tions, express opinions, and state preferences about treatments
during office visits with physicians have measurably better
health outcomes than patients who do not” (93, p. 497).
Tools that assist clinicians in engaging patients in SDM
can greatly improve the sharing of power and responsibility
for treatment, thus minimizing passivity on the patients part
and increasing their engagement (94). For patients facing
treatment or screening decisions where the choices are
“close calls” because of risks, benefits, scientific uncertainty,
or variation in patient preferences for possible outcomes,
decision aids have emerged to facilitate SDM. Their pur-
pose is not to persuade but to improve patient knowledge
and to clarify the importance of their preferences for
the resulting outcomes in the decision-making process.
These decision aids provide information about the disease, the
risks and benefits of treatment or screening options, and their
associated outcomes. Decision aids have been shown to improve
knowledge, reduce decisional conflict due to feeling uninformed
or unclear about personal values, increase active participation in
decision-making, and reduce indecision (95). This evidence of
benefit has led to the development and introduction of concepts
such as informed patient choice as health policy, wherein deter-mining decision quality involves assessing patient knowledge and
measuring the concordance between patient health goals (prefer-
ences) and the choice of treatment (96–98).
The use of SDM tools also has the potential to reduce
healthcare costs. When using such tools, patients in con-
junction with their physicians often choose more conserva-
tive treatments (89,99). Additionally, SDM tools may make
physicians less vulnerable to liability concerns (100). This
may achieve lower healthcare expenditures by reducing
unnecessary procedures and improving patient satisfaction.
CVD is particularly well suited to the use of SDM tools.
First, the plethora of guidelines and evidence-based thera-
pies form a solid foundation from which evidence can be
distilled and shared with patients. Furthermore, numerous
validated risk models of outcomes exist and can be used to
inform patients of their likely outcomes, based on the results
of previously treated patients (101). Second, there are many
treatments for which no differences in outcomes are clear, or
the treatment alternatives result in trade-offs, increasing the
risk of one outcome and decreasing the risk of another so
that patients’ values and perspectives may be the appropriate
driving force in decision-making. For example, bare-metal
stents result in more frequent repeat procedures than drug-
eluting stents (102,103), but they require a shorter duration
of dual antiplatelet therapy compared with drug-eluting
stents (104). Thus, patients concerned about bleeding/
bruising—or medication costs—may select a bare-metal
stent, even if a drug-eluting stent might minimize the
likelihood of restenosis (101). An important opportunity for
supporting PCC and shared decision-making is to extend
valid prediction models to the clinical encounter so that
individualized estimates of outcomes are available to assist
patients and clinicians in selecting therapy aligned with
patients’ tolerance for risks and expected benefits. Although
traditional outcomes have focused upon mortality, expand-
ing these models to patient-centered health status outcomes
could support an even greater focus on PCC that enables
patients to choose therapies based upon their goals and
preferences.
3.6. Collaborative Care Planning and Goal Setting
3.6.1. Recommendation
Easy-to-use and inexpensive self-management systems
should be readily available to patients, and a reporting
mechanism must be available to provide patient-
collected data back to clinicians so that they may provide
appropriate feedback and care so that the healthcare
team, which includes the patient, can conduct appropri-
ate collaborative care planning and goal setting.
Moving 1 step beyond SDM, collaborative care planning
refers to the process by which health and social profession-
als, patients, care givers, and families interact to develop and
plan a management strategy around a patient’s care (105).
Although SDMwith decision aids typically involves making
difficult treatment choices, caring for chronic conditions
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and the patient and potentially their caregivers or family
(106). Goals for these interactions include the acquisition of
knowledge and skill that leads to confidence and patient
empowerment to manage their chronic disease (73). One
result of collaborative care planning is the development of
an action plan or written instructions to patients after a visit
or upon discharge. Action plans have been examined in HF
and found to improve recognition of disease exacerbations,
to improve the initiation of the appropriate therapy, and to
reduce combined mortality or hospitalizations (107,108).
This methodology is currently being tested in a larger study
(109). There has also been increased interest in the incor-
poration of palliative care consultations and planning for
advanced HF (110,111).
Although inclusion of the patient and his or her family in
the collaboration process is critical, interprofessional collab-
oration, which refers to health professionals working to-
gether to improve the health of a patient, should also be
emphasized. Limited available evidence suggests that inter-
professional collaboration can improve healthcare processes
and outcomes. Its benefits are promising but not yet proven
(112).
A systematic review of such care delivery identifies 3
alternative approaches for HF, as an example: 1) multidis-
ciplinary interventions to bridge the gap between hospital
admission and discharge (to home or to transitional care);
2) case management interventions involving telephone
follow-up and home visitations after discharge; and
3) specialty clinic follow-up (113). These approaches can
also be considered for other CVDs. Case management
tended to reduce all-cause mortality and HF admissions.
Randomized controlled trials of a multidisciplinary inter-
vention demonstrated reduced HF admissions, but no
studies of the effect of specialty clinic care alone were found
(113–117). Tying closely to the collaborative care planning
model, mutual goal setting has long been recognized as an
essential component of care in order to achieve optimal
health outcomes (118). The rise in the numbers of persons
living with chronic cardiovascular conditions has brought
renewed recognition of the importance of mutual goal
setting. Long-term management of chronic conditions,
such as hypertension, coronary heart disease, and HF,
requires that patients follow complex therapeutic regimens.
Clinicians can make recommendations, but if these recom-
mendations are not understood by patients or are incongru-
ent with patients’ values, goals, and culture, it is unlikely
that patients will follow the recommendations and perform
the necessary self-care behaviors.
Interventions that incorporate mutual or collaborative
goal setting have demonstrated efficacy in increasing self-
care behaviors and reducing distress among persons with
cardiovascular conditions. For example, Moore et al. (119)
implemented the CHANGE (Change Habits by Applying
New Goals and Experiences) intervention using a random-
ized controlled trial design among 250 patients who had arecent cardiac event (angioplasty, coronary artery bypass
surgery, or myocardial infarction). The intervention—
guided by cognitive behavioral theories of self-efficacy (120),
xpectancy-value (121), social problem-solving (122), and
elapse prevention (123)—incorporated goal setting with
atients to help them maintain the exercise learned during
ardiac rehabilitation. The intervention was successful: pa-
ients in the usual care group were 76% more likely to stop
xercising, in comparison to the CHANGE group, in the
ear following the cardiac rehabilitation program (hazard
atio  1.76; 95% confidence interval  1.08 to 2.86, p 
0.02).
Dunbar (124) evaluated an educational and family part-
nership intervention designed to improve self-management
of dietary sodium intake among patients with HF. Patients
and their family caregivers were assigned to an educational
intervention alone (n  29; patient and family caregiver
dyads) or an educational and family partnership support
intervention (n  32 dyads) that incorporated mutual goal
setting. The patients who received the family intervention
had significantly decreased urinary sodium levels at 3
months after baseline, and more patients in this group
decreased their urinary sodium by 15% (p  0.04). Taken
together, these studies provide evidence that mutual goal
setting is an important part of interventions designed to
change patient behaviors.
3.7. Patient Empowerment and Self-Management
3.7.1. Recommendation
Patients should be encouraged to accept responsibility
for managing their health condition and work collabora-
tively with their healthcare team.
Patient empowerment and self-management is the final
element of PCC. Studies have shown that many patients
desire a partnership with clinicians in which clinicians
include patients in the discussion of health goals, treatment
options, risks versus benefits, and costs of care (125). The
concept of patient empowerment espouses that patients
accept responsibility for managing their health and medical
conditions and work collaboratively with the healthcare
team. For chronic illnesses such as CVD, the patient is the
principal caregiver responsible for interpreting and reporting
symptoms correctly, as well as using medications appropri-
ately in the context of social and economic circumstances
(126). Patients can self-identify problems and healthcare
team members provide self-management education, not
orders, that assist patients in taking measures that will
improve health (127). Patient self-management skills are
applied to physical health, psychological functioning, and
social aspects of chronic illness (127,128). Patients desire
tools and services that help them and their caregivers better
manage their conditions and achieve their mutually agreed
upon goals (129). For example, clinicians can empower
patients by supporting them through referrals to culturally
appropriate condition-specific support groups, as well as
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portation, assistance with activities of daily living, and
medication therapy management services (127,130,131).
4. Patient-Centered Care and
New Practice Challenges
4.1. Recommendation
Interventions need to be designed and implemented to
support the patient and family caregivers in order to
achieve optimal health outcomes for patients and their
families.
4.2. Impact of Technology
Patients make use of the Internet and other technology and
information transfer on an everyday basis for news-
gathering, shopping, e-mail messaging, and access to health
information. In 2004, the Pew Internet and American Life
Project (132) estimated that on a typical day, 70 million
Americans went online and 7 million looked for health or
medical information. The Pew Project also estimated that
85% of women and 75% of men as users of online resources
had searched for health information at least once in the past.
As a result of the tremendous amount of research many
patients do, they are transforming themselves from helpless
patients to medical end users as eloquently described by
Ferguson in his editorial (133). In fact, the number of
Medline searches performed by directly accessing the data-
base at the National Library of Medicine increased from
7 million in 1996 to 120 million in 1997, when free public
access became available; the new searches were attributed
primarily to nonphysicians (134).
Although increasing numbers of patients are seeking
health information via the Internet, relatively few commu-
nicate with their clinicians electronically. In a survey of
primary care providers in the Boston area, 75% of physicians
reported utilizing e-mail to communicate with patients, but
they did so with only 5% of their patient population (135).
When surveyed, a majority of patients would be interested
in communicating with their clinicians via e-mail (136).
Due to the asynchronous nature of electronic communica-
tions, it is most appropriate for nonurgent consultations,
test results, and prescription refills. The American Medical
Association has established guidelines for the use of
clinician-to-patient e-mail communication (137). Secure,
encrypted systems through which patients can access med-
ical records and test results, request refills, and communicate
nonurgent issues with providers are increasingly becoming
available (138).
Electronic health records are revolutionizing medical
care. They enable clinicians to access, store, and organize
patient encounters, tests, and images into 1 easily accessible
interface. They also allow patients unprecedented access to
their own records, correspondence, and laboratory tests. In
some cases, patients may, via a secure login, access theirlatest test results from their own home. In other cases,
patients may request refills, correspond with their care
providers, or pay their medical bills. Electronic health
records are also affecting patient care in other ways. They
may automatically research information about potential
drug interactions, remind clinicians about past due screen-
ing, and help clinicians provide quality guideline-driven
care.
Electronic prescribing is another innovation that has
positively affected patient care. Ammenwerth et al. (139)
conducted a systematic review of the literature with regard
to e-prescribing and concluded that 14 of the 25 studies that
analyzed the effects on the medication error rate, 23 showed
a relative risk reduction of 13% to 99%, and a majority of the
studies examined showed a 30% to 98% relative risk reduc-
tion in adverse events. Therefore, e-prescribing has proven
to help patients get the proper medication the first time and
with many e-prescribing services, the pharmacy can either
deliver or remind the patient to pick up the medicines,
which may improve adherence.
Personal health records (PHR) or personal health vaults
are becoming common. A PHR is a computerized applica-
tion that stores an individual’s personal health information.
Many large software vendors have created personal health
vaults, which allow patients to store their own medical
histories, prescriptions, blood pressure readings, and lab
results. With a PHR, patients can keep track of their own
medical histories and records, as well as share them with
their healthcare team. With this innovation, patients can
ensure that virtually any caregiver with Internet access has
tests, encounters, and a self-reported history available to
them whenever needed—especially in emergencies. Most of
the PHRs also allow patients the ability to research their
health conditions, which enables them to learn more about
their own medical conditions and treatments. The vast
majority of Internet users surveyed in a Harris Interactive
Poll thought that having a PHR would be beneficial and
necessary to help with providing excellent care (140,141).
Some vendors have also started to initiate patient manage-
ment protocols. The U.S. Department of Health and
Human Services and the Surgeon General are promoting
the use of PHR (142).
The Information Age has several pitfalls with regard to
patient access. Medical information, when taken in isolation
and without formal medical training, can often lead to
out-of-context diagnoses and treatment recommendations.
The information quality and sources are highly variable on
the Internet and, therefore, warrant further verification and
discussion with patients (143,144). Additional concerns
come from the proprietary format in which many PHR and
electronic health records store data that can result in a lack
of interoperability or transfer of information into other
formats and other vendor platforms (145). Direct-to-
consumer content that is provided by industry is often
difficult to differentiate from that provided by scientists and
clinicians; anecdotes and testimonials may appear very
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include patient privacy and confidentiality, such that secu-
rity, encryption, and identity verification are necessary.
Lastly, access to technology has uneven distribution (146).
Despite all of the features, power, and convenience of a
connected patient and clinician, many people of varying
socioeconomic groups simply do not have the ability,
financial wherewithal, or willingness to be an avid technol-
ogy user (147). As such, access is not equal to all, and needs
to be strongly considered in any relationship between
clinician and patient. In many studies, education and race
were significant predictors of online health-seeking behavior
(148,149).
4.3. Complexity of Care Strategies With Self-Care
Managing the complex therapeutic regimens for chronic
cardiovascular conditions often requires lifelong behavioral
change and self-care, which may be difficult for patients to
understand (150). Self-care is a naturalistic decision-making
process about choices of behaviors that individuals make to
maintain physiologic stability (self-care maintenance) and to
manage symptoms when they occur (self-care management)
(151). Self-care maintenance includes routine monitoring of
symptoms and medication, as well as dietary adherence. A
lack of adherence to prescribed medication and dietary
regimens is associated with adverse outcomes among pa-
tients with hypertension, post-myocardial infarction, and
HF. The more complex process of self-care management
includes interpreting, evaluating the significance of, and
taking the appropriate actions to treat symptoms (151).
In patients with acute myocardial infarction, the difficulty in
interpreting and managing symptoms leads to a delay in
seeking treatment that increases the likelihood of further
infarction and death (152). In patients with HF, the
difficulty in interpreting and managing symptoms may lead
to further impairment of proper function and quality of life,
unnecessary hospitalizations, and premature death (153).
A number of patient factors increase the complexity of
self-care and makes learning the new behaviors and skills
required more challenging, including older age, decreased
health literacy, cognitive impairment, and the individual
variation in symptom experience. In a study among 77 older
patients with HF, most had inadequate cognitive and
emotional responses for effective symptom management
(154). Morrow et al. (155) focused on health literacy and
designed patient-centered instructions. These instructions
were compared with standard pharmacy instructions among
32 older patients with HF to improve medication adherence
by improving patient knowledge. Patient-centered instruc-
tions were designed to meet patients’ needs by decreasing
sensory and cognitive demands. For example, large print
and shorter sentences were used in the instructions. The
order of information in the instructions was organized
according to the way patients expect content to be pre-
sented. Icons were used to match instructional content to
pictures in order to facilitate learning. Patients were betterable to recall and understand the patient-centered instruc-
tions. Furthermore, patients preferred patient-centered in-
structions (156). Cognitive impairment may prevent pa-
tients from learning new skills and abilities. Among 1,573
people over age 55, impaired cognition was an independent
predictor of nonadherence to antihypertensive medications
(157). One-fourth to one-half of patients with HF have
cognitive impairment that may explain nonadherence
(158,159).
Ideally, patients are able to self-manage their own ther-
apeutic regimens. However, with advanced cardiovascular
conditions, patients may have significant impairments in
physical, emotional, and cognitive function and require
assistance from family members. As much as 90% of chronic
illness care in the United States is delivered by family
caregivers (160), and in some studies, family caregivers had
increased mortality compared with noncaregivers (161).
Family caregivers of HF patients report high levels of
physical and emotional distress, and in a recent study, 41%
of 335 caregivers believed they needed to be available 24
hours a day to assist patients (162,163). Strategies for
improving self-care among vulnerable patients who are
unable to perform much of their own self-care need to
incorporate family members.
4.4. Systemic Approach to Episodic Care
4.4.1. Recommendation
PCC demands that the healthcare system develop a
means of accumulating and sharing information across
all encounters of a single patient to the greatest extent
possible. This information must be easily accessible,
searchable, and organized in a systematic fashion so that
it can be used to readily support evidence-based ap-
proaches with the ultimate goal of improving chronic
disease management.
The basic tenets of PCC require a transition of healthcare
delivery away from the traditional practice of episodic care
toward a systemic approach. The 2001 Institute of Medicine
report recognized that the care delivery system of the United
States has traditionally been designed for acute episodic
care, whereas the patient care needs of the populace has
been shifting toward that of chronic conditions (1). Data
show that chronic conditions are the leading cause of
morbidity and mortality in the United States, affecting
nearly one-half of the population and accounting for three-
quarters of healthcare dollars (164). It is also known that
there are significant potential barriers to obtaining needed
care by those who do not have an established source of care,
while at the same time, there are improved outcomes with
potentially lower costs among those individuals who have an
established and continuous source of care by the same
clinician (165–169). It has been estimated that it can take up
to 4 visits with a clinician before the acquired knowledge
can be sufficiently synthesized to affect diagnostic testing
strategies and impart changes in anticipatory care (170). It
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an individual patient and to develop a management plan
that considers an individual’s multiple medical and social
variables. Each meeting with the same clinician allows for
accumulation and synthesis of information that is impossi-
ble to capture on any 1 episodic encounter.
It takes more than a single continuous knowledgeable
clinician to sustain PCC. The healthcare delivery system
itself must also be reformed to provide what has been
termed as informational continuity (171). Informational
continuity contributes to the systemic approach of medicine
by providing a collection of medical and social information
that is available to any healthcare professional caring for any
individual, which allows systematic communication about
the information among all caregivers. In the traditional
episodic style of healthcare delivery, caregivers and health-
care organizations often operate in silos, providing care
without the benefit of complete information about the
patient and the medical care.
4.4.1.1. PERSONALIZED CARE IN THE AGING POPULATION
4.4.1.1.1. RECOMMENDATION. Given the intricacies of age
and multiple morbidities, personalized medicine should
be used as an alternative treatment paradigm; however,
personalized medicine can only be sustained if patients
achieve clear and realistic understandings of therapeutic
options, including attention to costs and treatment
limitations.
The importance of personalized medicine is driven in part
by increased longevity and by the high prevalence of
multiple morbidities within the growing population of older
adults. The average American life span has increased from
50 years in 1900 to almost 80 years in 2011, and even longer
life spans are anticipated in the decades ahead. By 2030, it
is projected that almost 20% of the U.S. population will be
65 years and older, with tripling of the subgroup aged 85
years and older by 2050 (172). Aging provokes ubiquitous
changes throughout the body, exacerbating vulnerabilities to
disease and to idiosyncratic responses to therapy (173–175).
Moreover, most older adults have multiple morbid condi-
tions and an associated likelihood of polypharmacy and
frailty, compounding their predisposition to acute and
chronic instability and to increased complexity of therapeu-
tic choices (173,175). The concept of personalized medicine
is very relevant for the management of patients with these
challenges. It becomes critically important to consider
unique outcome goals for each patient and to then deter-
mine the complex interaction of multiple morbidities, med-
ications, and aging changes before therapy is initiated.
Aging changes in the cardiovascular system are usually
predictable, limiting cardiovascular reserves, and increasing
vulnerability to CVD (173,175). However, pervasive changes
also occur in other organ systems, adding to cardiovascular
instability, particularly because noncardiac stresses can more
readily overwhelm the diminished cardiovascular physiological
reserves. As an example, consider the common case of a simpleurinary tract infection causing both non–ST-segment elevation
myocardial infarction and mental status changes in an other-
wise functional nonagenarian.
Cascading pathological effects (e.g., noncardiac stresses,
such as an infection) also tend to occur, and more often
provoke cardiovascular instability, which in turn exacerbate
noncardiac instability (such as bowel ischemia and/or renal
failure). High mortality, poor functional status, prolonged
hospitalizations, adverse drug events, duplicative tests, and
conflicting medical advice all increase in association with
aging and multiple morbidities.
Personalized medicine represents an alternate therapeutic
paradigm, such that the intricacies of age and multiple
morbidities are systematically addressed as an aggregate
issue. Ideally, this approach still draws upon evidence-based
insights but with more emphasis on the context of multi-
system aging, morbidities, polypharmacy, psychosocial fac-
tors, and personal preferences.
The goal of providing personalized medicine to the
expanding population of eligible patients remains a daunt-
ing challenge. Baby boomers represent a particular challenge
because they are a patient group that has been associated
with entitlements, high costs, and inefficiencies, and their
underlying consumerist patterns may drive unrealistic ex-
pectations of care. Personalized medicine can only be
sustained if patients achieve clear and realistic understand-
ings of therapeutic options, including attention to costs and
treatment limitations. Indeed, sometimes, the intensive
drive to do everything possible can lead to a poorer quality
of life. Informed consent and patient education techniques
can evolve to better respond to these challenges.
4.4.1.2. PATIENT-CENTERED MEDICAL HOME
4.4.1.2.1. RECOMMENDATION. A patient-centered medical
home for cardiovascular care should be developed and
demonstrated to manage patients with advanced cardiac
disease across the continuum of care from the stable
outpatient environment to the level of intensive in-
hospital care without changing care teams.
The PCMH has been proposed as a model of healthcare
delivery that can provide care that is “accessible, continuous,
comprehensive and coordinated and delivered in the context
of family and community” (176). The initial PCMH con-
cept embodied primary care physicians as the principal
physicians, with specialists acting as consultants (177).
However, as the intricacy of cardiovascular care strategies
increase, the necessity for coordinated care directed by care
team leaders who are expert in all aspects of CVD is clear.
The PCMH for CVD (PCMH-CVD) can address this
model for cardiologists and their patients, providing for the
total care of these complex patients in an environment led
by physicians with special expertise in heart and vascular
disorders (178). When coupled with the extensive patient
education efforts employed by cardiologists to facilitate
self-care in chronic illness, these clinicians find themselves
uniquely poised to deliver this comprehensive care.
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age of patients with CVD as their predominant malady will
further increase the requirement for advanced cardiovascular
care (179). This coupled with the exponential increase in the
sophistication of cardiovascular management modalities make
the PCMH-CVD a desirable and inevitable solution. This will
become more relevant as healthcare payment reform results in
the move away from fee-for-service management to a reim-
bursement strategy based upon episodes of care.
The PCMH-CVD will consist of a team directed by
cardiologists with advanced training in CVD management.
This care team will include nurse practitioners, physician
assistants, pharmacists, registered nurses, medical technol-
ogists, nurse educators, and the support staff found in all
PCMH (131). In addition, technologists with expertise in
advanced imaging such as echocardiography, myocardial
perfusion imaging, computed tomography, and implanted
cardiac device management will be part of this PCMH-
CVD environment. Expanded access will include not only
the availability of patient appointments but also the utiliza-
tion of electronic communication among care team mem-
bers and patients to increase access and reduce delays, for a
more therapeutic modification inherent with scheduled
face-to-face visits.
A unique feature of the cardiovascular PCMH-CVD will
be its ability to manage patients with advanced cardiac
disease across the continuum of care from the stable
outpatient environment to the level of intensive in-hospital
care without changing care teams. Likewise, the transition
from hospital care to intensive outpatient treatment to
typical outpatient care either in a home environment or in
subacute care facilities will be seamless and efficient, partic-
ularly for those with multiple concurrent illnesses and the
potential for frequent hospitalization. This will hopefully
improve quality, decrease readmissions, and reduce cost.
Finally, the PCMH-CVD will provide aggressive coor-
dinated evidence-based risk factor modification not only for
secondary prevention but also for the primary prevention of
all forms of CVD by education in relation to lifestyle
changes and appropriate medical intervention. In addition,
the PCMH-CVD will provide the monitoring of complex
medication regimens and chronic disease management in a
coordinated and cost-efficient manner. Through the devel-
opment of the PCMH-CVD, persons with complex CVD
will experience enhanced health benefits at a reduced cost in
a comfortable, pleasant, and patient-centered environment.
4.5. Barriers to Patient-Centered Care
4.5.1. Recommendations
Sufficient financial reimbursement and/or financial in-
centive that accommodate for additional clinician time to
provide PCC needs to be developed and implemented.
Nonphysician members of the care team should be
empowered to provide PCC to help manage the increas-
ing demands of patients with chronic heart disease.To provide PCC, physicians and other clinicians require
focused education on PCC (19) and properly aligned
financial incentives to apply this approach to chronic disease
management (20). An obstacle to PCC is clinician time and
reimbursement. As the physician shortage grows and the
population of older individuals increases, less time will be
available for physicians to provide the personal and frequent
surveillance needed for high-quality PCC. Escalating med-
ical costs and reduced reimbursement are other challenges
for developing PCC programs in individual practices.
Reimbursement to a PCMH using a partial capitation
model makes it well suited to follow patients with chronic
HF, cardiac transplantation, implanted devices, and other
chronic cardiac disorders that require frequent surveillance
and changes in medication, by replacing the fee-for-service
model in these cases. Alternatively, cardiology practices
consisting of teams of physicians, nurses, advanced practice
nurses, physician assistants, pharmacists, social workers,
dieticians, and others could provide a comprehensive, lon-
gitudinal care system for the more complex patients with
chronic heart disease in a specialty-oriented PCMH. The
PCMH-CVD can also be incorporated into a core program
for larger accountable care organizations as new models of
reimbursement emerge.
With the continuously increasing number of patients
with chronic heart disease, and the growing shortage of
healthcare clinicians, providing an environment where pa-
tients are engaged in their care and educated about the
medical and behavioral aspects of their disorders has become
an essential component of long-term care. Considering
patient preferences, differing lifestyles, special population
needs, and improving communication tools, the concept of
PCC has emerged to accommodate all of these factors in a
new model of care. Developing programs within clinical
practices to account for PCC is best done with a team care
concept where nonphysician clinicians working with physi-
cians provide these factors in a patient-centric comprehen-
sive care model to manage the increasing care demands of
patients with chronic heart disease. Essential to the success
of PCC is the need for patients to become engaged in their
care and accept some responsibility to participate in their
care plans. Ongoing communication using the concepts of
PCC should improve care for the growing population of
patients with chronic heart disease. Recognition of this form
of care is still needed in healthcare systems throughout the
world, and new methods for reimbursement are still needed
to maintain the multidisciplinary healthcare team that is
fundamental for PCC.
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